NCT05081648 (MuST) is a NA clinical trial of CT MuST in Chronic Kidney Diseases, sponsored by Fresenius Medical Care Deutschland GmbH.

Who is sponsoring NCT05081648?

NCT05081648 is sponsored by Fresenius Medical Care Deutschland GmbH.

What drugs are being tested in NCT05081648?

Interventions in NCT05081648: CT MuST, Rope-ladder cannulation technique.

What condition does NCT05081648 study?

NCT05081648 studies Chronic Kidney Diseases, Hemodialysis, Vascular Access Complication, Hemodialysis Access Failure, Arteriovenous Fistula.

Is NCT05081648 still recruiting?

NCT05081648 is currently completed. Last updated 13 October 2023.

Last reviewed 2023-10-13 · How we verify

NCT05081648: MuST

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Must Cannulation Technique of Vascular Access in Patients Undergoing Haemodialysis: Contributions for a Safe Nursing Intervention

Completed NA Last updated 13 October 2023

What this trial tests

NA trial testing CT MuST in Chronic Kidney Diseases in 101 participants. Completed in 30 April 2023.

Timeline

3 January 2022

Primary endpoint
30 April 2022

30 April 2023

Quick facts

Lead sponsor	Fresenius Medical Care Deutschland GmbH
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	101
Start date	3 January 2022
Primary completion	30 April 2022
Estimated completion	30 April 2023
Sites	3 locations across Portugal

Drugs / interventions tested

CT MuST
Rope-ladder cannulation technique

Conditions studied

Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
Hemodialysis — all drugs for Hemodialysis →
Vascular Access Complication — all drugs for Vascular Access Complication →
Hemodialysis Access Failure — all drugs for Hemodialysis Access Failure →

Sponsor

Fresenius Medical Care Deutschland GmbH — full company profile →

Who can join

18 and older, any sex, with Chronic Kidney Diseases or Hemodialysis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this study are to: * Determine the AVF (arteriovenous fistula) survival of patients submitted to MuST compared to those submitted to RL (rope-ladder). * Determine the AVF (arteriovenous fistula) complication rate of patients submitted to MuST compared to those submitted to RL (rope-ladder). * Analyze the intensity of pain perceived by the patient with each cannulation technique under study.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

A randomised control trial protocol of MuST for vascular access cannulation in hemodialysis patients (MuST Study): contributions for a safe nursing intervention.
Peralta R, Wammi A, Stauss-Gabo M, Dias Ó, et al · · 2022 · cited 3× · PMID 35729492 · DOI 10.1186/s12882-022-02842-3
A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention.
Peralta R, Rocha R, Dias AS, Martins A, et al · · 2026 · PMID 42004653 · DOI 10.1016/j.xkme.2026.101305
A Randomized Control Trial of MuST for Vascular Access Cannulation in Hemodialysis Patients: Contributions for a Safe Nursing Intervention
Peralta R, Rocha R, Dias A, Martins A, et al · · 2026

Verify or expand the search:

Other recruiting trials for Chronic Kidney Diseases

Currently open trials in the same condition.

NCT06593392 — Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus · Phase 2 · recruiting
NCT07358572 — Eye-Brain-Kidney in CKD · recruiting
NCT06463483 — Automated Insulin Delivery in Adults With Advanced Kidney Disease · NA · recruiting
NCT06927024 — Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD) · NA · recruiting
NCT07115953 — Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension · NA · recruiting

Other Fresenius Medical Care Deutschland GmbH trials

Trials by the same sponsor.

NCT06236984 — Retrospective Data Analysis of CKRT (Continuous Kidney Replacement Therapy) Treatments in Adult Mode With multiFiltrateP · completed
NCT05441020 — Development, Feasibility Testing and Validation of a Survey Set to Measure Patient-Reported Outcomes Among Hemodialysis · completed
NCT05315817 — Safety and Performance Evaluation of multiPlus Dialysate During CRRT · NA · terminated
NCT05142501 — Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy · terminated
NCT04871893 — Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05081648 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fresenius Medical Care Deutschland GmbH
Last refreshed: 13 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05081648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing